Your Article Summary
See Latest ArticlesPrevalence and Risk Factors for Aminoglycoside Nephrotoxicity in Intensive Care Units
Antimicrobial Agents and Chemotherapy, 06/26/09
Oliveira JFP et al. - AKI was frequent among ICU patients receiving an aminoglycoside, and it was associated with a high rate of mortality. The presence of diabetes or hypotension and the use of other nephrotoxic drugs and iodinated contrast were independent risk factors for the development of aminoglycoside-associated nephrotoxicity.
Related Articles
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors
European Journal of Cancer, 10/23/09
Relevance Score: 85%
What I tell my patients about contrast medium nephrotoxicity
British Journal of Renal Medicine, 10/27/09
Relevance Score: 82%
Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in Children
Journal of Clinical Oncology, 10/26/09
Relevance Score: 82%
Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells
American Journal of Physiology: Renal Physiology, 11/12/09
Relevance Score: 80%
Renal Dendritic Cells Ameliorate Nephrotoxic Acute Kidney Injury
Journal of the American Society of Nephrology, 11/04/09
Relevance Score: 80%
Today in Chronic Dz/Renal Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of HIV-Infected Patients With ESRD
Advances In Chronic Kidney Disease , 12/18/09
Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
Transplantation Proceedings, 12/18/09
Hyperuricemia, Gout, and Renal Function After Liver Transplantation
Transplantation, 12/18/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, 12/18/09
Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
Transplantation Proceedings, 12/18/09
Low-Dose Dopamine in Kidney Transplantation
Transplantation Proceedings, 12/18/09